Literature DB >> 11532602

Bromodomain motifs and "scaffolding"?

G V Denis1.   

Abstract

Bromodomain-containing multiprotein complexes share some of the properties of signal transduction scaffolds. Insights from MAP kinase signaling scaffolds, for example, may provide useful perspectives for future studies of bromodomain proteins. The regulatory processes of modification (phosphorylation, acetylation, ubiquitination), turnover, nuclear compartmentalization, feedback regulation and signaling pathway specificity are all likely to contribute to the mechanisms by which bromodomain-containing multiprotein complexes control transcription.

Mesh:

Substances:

Year:  2001        PMID: 11532602      PMCID: PMC3042883          DOI: 10.2741/A668

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  36 in total

1.  Nuclear shuttling of yeast scaffold Ste5 is required for its recruitment to the plasma membrane and activation of the mating MAPK cascade.

Authors:  S K Mahanty; Y Wang; F W Farley; E A Elion
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

Review 2.  Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals.

Authors:  A J Whitmarsh; R J Davis
Journal:  Trends Biochem Sci       Date:  1998-12       Impact factor: 13.807

3.  Routing MAP kinase cascades.

Authors:  E A Elion
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

4.  Mitotic inactivation of a human SWI/SNF chromatin remodeling complex.

Authors:  S Sif; P T Stukenberg; M W Kirschner; R E Kingston
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

5.  Transcription. A growing coactivator network.

Authors:  R Janknecht; T Hunter
Journal:  Nature       Date:  1996-09-05       Impact factor: 49.962

Review 6.  The riddle of MAP kinase signaling specificity.

Authors:  H D Madhani; G R Fink
Journal:  Trends Genet       Date:  1998-04       Impact factor: 11.639

7.  Dimerization of Ste5, a mitogen-activated protein kinase cascade scaffold protein, is required for signal transduction.

Authors:  D Yablonski; I Marbach; A Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain.

Authors:  B Bourachot; M Yaniv; C Muchardt
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

9.  The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.

Authors:  C Muchardt; J C Reyes; B Bourachot; E Leguoy; M Yaniv
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

10.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.

Authors:  X J Yang; V V Ogryzko; J Nishikawa; B H Howard; Y Nakatani
Journal:  Nature       Date:  1996-07-25       Impact factor: 49.962

View more
  16 in total

Review 1.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

Review 2.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

3.  Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.

Authors:  Gerald V Denis; Mark E McComb; Douglas V Faller; Anupama Sinha; Paul B Romesser; Catherine E Costello
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

4.  Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.

Authors:  Takashi Umehara; Yoshihiro Nakamura; Moon Kyoo Jang; Kazumi Nakano; Akiko Tanaka; Keiko Ozato; Balasundaram Padmanabhan; Shigeyuki Yokoyama
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

5.  Brd2 disruption in mice causes severe obesity without Type 2 diabetes.

Authors:  Fangnian Wang; Hongsheng Liu; Wanda P Blanton; Anna Belkina; Nathan K Lebrasseur; Gerald V Denis
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

Review 6.  BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.

Authors:  Guillaume P Andrieu; Jordan S Shafran; Jude T Deeney; Kishan R Bharadwaj; Annapoorni Rangarajan; Gerald V Denis
Journal:  J Leukoc Biol       Date:  2018-03-01       Impact factor: 4.962

Review 7.  Clinical trials for BET inhibitors run ahead of the science.

Authors:  Guillaume Andrieu; Anna C Belkina; Gerald V Denis
Journal:  Drug Discov Today Technol       Date:  2016-07-21

Review 8.  An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.

Authors:  Gerald V Denis; Barbara S Nikolajczyk; Gavin R Schnitzler
Journal:  FEBS Lett       Date:  2010-05-21       Impact factor: 4.124

9.  Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.

Authors:  Saumya Shree Gupta; Tobias Maetzig; Goedele N Maertens; Azar Sharif; Michael Rothe; Magdalena Weidner-Glunde; Melanie Galla; Axel Schambach; Peter Cherepanov; Thomas F Schulz
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

10.  E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.

Authors:  Rebecca J Greenwald; Joseph R Tumang; Anupama Sinha; Nicolas Currier; Robert D Cardiff; Thomas L Rothstein; Douglas V Faller; Gerald V Denis
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.